we conclude that the antikeratinizing basis for retinoid activity comprises : ( 1 ) dose-dependent alterations in transepidermal water loss and ( 2 ) epidermal and stratum corneum loosening , which may , in turn , lead to loss of epidermal cohesion and abnormal barrier function .
C0014520
epidermal
C0221921
stratum corneum